KIFC1 inhibitor CW069 induces apoptosis and reverses resistance to docetaxel in prostate cancer
Yohei Sekino(Hiroshima University), Akio Matsubara(Hiroshima University)
Cited by 0
Related Papers
KIFC1 Inhibitor CW069 Induces Apoptosis and Reverses Resistance to Docetaxel in Prostate Cancer
|Journal of Clinical Medicine|2019|55
PTEN Is Involved in Sunitinib and Sorafenib Resistance in Renal Cell Carcinoma
|Anticancer Research|2020|31
Restoration of fibroblast growth factor receptor 2IIIb enhances the chemosensitivity of human prostate cancer cells
|Oncology Reports|2014|15